Calypte Biomedical Corp (fka CBMC)

[cal_pn]

investor 100,
imo they will get approval in China (rather sooner than later), then everything depends on whether they can successfully market the test(s) worldwide. It is probably fair to say that they have not completely proved it yet. The markets are difficult to assess but the big potential is definitely there.

Entering in the next couple of weeks could be a very good move (expect upcoming sFDA approval) for short and long term.

They can break even rather quickly if revenues start to come in and financing is not critical anymore for the next future but dilution could become an issue again when sales will take longer than expected.

Success in the US will probably require more time but is easier to predict.

Cal